Identifying successful biomarkers for patients with non-small-cell lung cancer

Documenti analoghi

• The crucial role of predicting brain metastases development in non-small cell lung cancer patients
  di: Addeo, Alfredo, et al.
  Pubblicazione: (2018)
• Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm
  di: Banna, Giuseppe Luigi, et al.
  Pubblicazione: (2020)
• How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere
  di: Banna, Giuseppe, et al.
  Pubblicazione: (2020)
• Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
  di: Chevallier, Mathieu, et al.
  Pubblicazione: (2021)
• Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic
  di: Friedlaender, Alex, et al.
  Pubblicazione: (2020)